Pediatric refractory immune thrombocytopenia: A systematic review
Pediatric Blood & Cancer · 2023-03 · 70 (3)
DOI: 10.1002/pbc.30173 ↗At a glance
Systematische Übersicht in Pediatric Blood & Cancer, published online on 2022-12-29. Written by Layan Ibrahim and 10 co-authors. Institution: Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Major MEDLINE topics: Purpura, Thrombocytopenic, Idiopathic, Thrombocytopenia. Cited 19 times so far (Crossref); 36 references.
Abstract (original language)
Pediatric immune thrombocytopenia (ITP) is an acquired disorder associated with autoimmune destruction and impairment of platelet production in children. Some children exhibit poor or transient response to ITP‐directed treatments and are referred to as having refractory ITP (rITP). There is currently no consensus on the definition of rITP, nor evidence‐based treatment guidelines for patients with rITP. After a survey of pediatric ITP experts demonstrated lack of consensus on pediatric rITP, we pursued a systematic review to examine the reported clinical phenotypes and treatment outcomes in pediatric rITP. The search identified 253 relevant manuscripts; following review, 11 studies proposed a definition for pediatric rITP with no consensus amongst them. Most definitions included suboptimal response to medical management, while some outlined specific platelet thresholds to define this suboptimal response. Common attributes identified in this study should be used to propose a comprehensive definition, which will facilitate outcome comparisons of future rITP studies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
- University of Ottawa, Faculty of Medicine, Ottawa, Ontario, Canada.
- Division of Hematology/Oncology, Department of Pediatrics, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.
- Department of Pediatrics, Baylor College of Medicine, Texas Children's Hematology Center, Houston, Texas, USA.
- Division of Pediatric Hematology and Oncology, New York Presbyterian Hospital/Weill Cornell Medical College, New York, New York, USA.
- Cancer and Blood Disorders Program, Children's Minnesota, Minneapolis, Minnesota, USA.
ORCID profiles: Layan Ibrahim, Selina X Dong, Shipra Kaicker, Rachael F Grace, Robert J Klaassen
Cite
APA
Ibrahim, L., Dong, S. X., O'Hearn, K., Grimes, A. B., Kaicker, S., FritchLilla, S., Breakey, V. R., Grace, R. F., Lebensburger, J. D., Klaassen, R. J., & Lambert, M. (2023). Pediatric refractory immune thrombocytopenia: A systematic review. Pediatric Blood & Cancer, 70(3). https://doi.org/10.1002/pbc.30173
Vancouver
Ibrahim L, Dong SX, O'Hearn K, Grimes AB, Kaicker S, FritchLilla S, et al. Pediatric refractory immune thrombocytopenia: A systematic review. Pediatric Blood & Cancer. 2023;70(3). doi:10.1002/pbc.30173
BibTeX
@article{Ibrahim2023,
author = {Ibrahim, Layan and Dong, Selina X and O'Hearn, Katie and Grimes, Amanda B and Kaicker, Shipra and FritchLilla, Stephanie and Breakey, Vicky R and Grace, Rachael F and Lebensburger, Jeffrey D and Klaassen, Robert J and Lambert, Michele},
title = {Pediatric refractory immune thrombocytopenia: A systematic review},
journal = {Pediatric Blood & Cancer},
year = {2023},
volume = {70},
number = {3},
doi = {10.1002/pbc.30173}
}
EUVIMED